Push Health Review 2026: Cost, How It Works, and GLP-1 Access

Last Updated: MARCH 2026

As of 2026, cost remains the most significant barrier to GLP-1 medication access, with a Navitus survey finding 68% of respondents citing expense as influencing their use [3]. Telehealth platforms like Push Health have emerged as a primary gateway for many seeking these highly effective weight loss and diabetes treatments. The platform provides a direct, on-demand connection to healthcare providers who can assess, diagnose, and prescribe, including GLP-1 agonists. This review unpacks Push Health’s model, its cost implications, medication access routes, and how it stacks up against more integrated GLP-1 weight management programs in the evolving 2026 landscape.

What is Push Health?

Push Health is a broader telehealth platform connecting patients with independent healthcare providers for various medical needs, from routine prescriptions to chronic condition management. Unlike dedicated GLP-1 clinics or weight management programs, Push Health operates as a marketplace for medical consultations. Patients select a provider, often based on reviews, location, or specialty, and engage in virtual consultations. The platform facilitates communication, medical record sharing, and prescription delivery to local pharmacies.

For those pursuing GLP-1 medications, Push Health offers a streamlined path to a prescription. Patients initiate a request, are matched with or choose a provider, and undergo a virtual evaluation. If deemed appropriate and medically safe, the provider can then issue a prescription for GLP-1 medications like Wegovy, Zepbound, Ozempic (off-label for weight loss), or Mounjaro (off-label for weight loss). The platform itself does not provide the medication, nor does it offer integrated lifestyle coaching, nutrition plans, or structured psychological support often found in specialized programs.

How Push Health Works for GLP-1 Prescriptions

The process of obtaining a GLP-1 prescription through Push Health typically involves several steps:

1. Patient Request: A patient signs up, creates a profile, and initiates a request for a specific service, such as “weight loss medication” or “GLP-1 consultation.” They may be asked to provide medical history, current medications, and relevant health metrics like BMI.
2. Provider Selection and Connection: Patients can browse available providers or be matched with one. Many providers on Push Health specialize in weight management and GLP-1 prescriptions. The initial interaction often begins with secure messaging within the platform, where the provider can ask preliminary questions.
3. Virtual Consultation: If the initial assessment suggests eligibility, a virtual consultation (video or phone call) is scheduled. During this consultation, the provider conducts a more thorough medical history review, discusses potential contraindications, and evaluates the patient’s suitability for GLP-1 therapy. This includes discussing potential side effects and monitoring requirements.
4. Prescription Issuance: If the provider determines a GLP-1 medication is clinically appropriate and safe, they will send an electronic prescription to the patient’s pharmacy of choice.
5. Follow-up Care: Ongoing follow-up appointments are necessary for dose titrations, monitoring side effects, and re-evaluating treatment efficacy. Patients typically schedule these directly with their Push Health provider.

The platform’s strength lies in its flexibility and accessibility, allowing patients to connect with providers from anywhere, often on short notice. However, the quality and comprehensiveness of care can vary depending on the individual provider’s practice model and experience.

Cost Structure and Medication Access in 2026

The cost associated with Push Health involves two primary components: the consultation fee and the medication cost itself.

Consultation Fees

Push Health providers set their own consultation fees, which are typically charged per appointment. These can range from approximately $60 to $100 for an initial consultation, with follow-up appointments often priced similarly or slightly lower. This is generally a one-time fee per visit, not a recurring subscription like many dedicated GLP-1 programs. This model can be more cost-effective for patients who primarily need a prescription and prefer to manage lifestyle changes independently.

Medication Costs and Access

This is where the financial landscape for GLP-1s becomes most complex and where Push Health, as a prescription facilitator, offers no direct cost relief beyond connecting patients to a prescribing provider. The actual cost of GLP-1 medications can be substantial. The Navitus survey from 2026 revealed that 24% of patients reported paying over $250 per fill, with approximately 8% paying over $500 per fill [3].

Several factors influence medication cost:

• Insurance Coverage: Many commercial insurance plans still have stringent criteria or outright exclusions for weight loss medications. While states are increasingly pushing for insurance mandates—with about 25 states implementing taxpayer-funded coverage between 2022 and 2024, and at least 14 more taking action in Q1-Q2 2025—access remains uneven [Pharmacy Times].
• Medicare Part D: A significant development for 2026 is the CMS payment demonstration starting in July, which will allow eligible Medicare Part D beneficiaries to have coverage for GLP-1 drugs with an out-of-pocket cost of $50 a month [National Consumers League]. This cap represents a dramatic improvement in affordability for a key demographic.
• Manufacturer Savings Programs: Many pharmaceutical companies offer savings cards or patient assistance programs that can significantly reduce the out-of-pocket cost for commercially insured patients who meet specific criteria.
• Compounded GLP-1s: Some Push Health providers may prescribe compounded versions of GLP-1s, often containing semaglutide or tirzepatide, obtained from compounding pharmacies. These are typically much less expensive than brand-name drugs. However, the FDA has issued clear warnings regarding compounded GLP-1s, stating, “Patients should be aware that compounded drugs do not have the same safety, quality, or effectiveness assurances as FDA-approved drugs” [2]. This option carries inherent risks, including variability in purity and potency, and patients should discuss these concerns thoroughly with their provider.

Push Health providers can guide patients on navigating these options, providing the necessary prescriptions and documentation for insurance appeals or savings programs. However, the onus of securing affordable medication often falls on the patient.

Push Health vs. Dedicated GLP-1 Programs

Push Health’s model contrasts sharply with comprehensive, dedicated GLP-1 weight management programs like Calibrate, Found, or the WeightWatchers Clinic. The differences lie primarily in their scope of service, cost structure, and integrated support.

Pros and Cons of Using Push Health for GLP-1 Access

Pros

• Accessibility: Push Health offers immediate access to a wide network of providers, often with appointments available quickly. This can be crucial for patients in rural areas or those with busy schedules.
• Cost-Effective Consultations: For patients primarily seeking a prescription, the per-consultation fee structure can be significantly cheaper than the monthly subscriptions of comprehensive GLP-1 programs, which bundle services they may not need or want.
• Provider Choice: Patients can often select providers based on their specific needs, reviews, or areas of specialization.
• Flexibility: The platform’s on-demand nature allows patients to manage their care at their own pace.

Cons

• Lack of Integrated Support: The most significant drawback is the absence of integrated coaching, nutritional guidance, exercise planning, or psychological support. For many, sustained weight loss with GLP-1s requires significant lifestyle modifications, which dedicated programs aim to facilitate. The STEP 1 trial demonstrated an average weight loss of 14.9% with semaglutide 2.4 mg, compared to 2.4% with placebo, but this was in conjunction with lifestyle intervention [1]. Without structured support, patients may struggle to maximize medication efficacy.
• Variable Provider Experience: While many excellent providers use Push Health, the quality and depth of GLP-1 expertise can vary. Patients must perform due diligence in selecting a provider.
• Medication Cost Burden: Push Health offers no direct solution for the high cost of GLP-1 medications. Patients must independently navigate insurance, prior authorizations, and savings programs. This remains a significant hurdle in 2026, despite growing state mandates and the upcoming Medicare Part D changes.
• Fragmented Care: Without a single, integrated program, care can feel fragmented. Lab orders, prescription refills, and follow-ups are separate steps, potentially requiring more patient initiative.

The Evolving GLP-1 Landscape in 2026

The market for GLP-1 medications is undergoing rapid transformation in 2026. Expanded uses of GLP-1s are projected to be a major driver of drug plan costs, with research exploring their efficacy in conditions like metabolic dysfunction-associated steatohepatitis and obstructive sleep apnea [Benefits Canada]. This broader application, coupled with rising demand for weight management, is increasing pressure on healthcare systems and insurers.

The regulatory and payment environments are also shifting. The July 2026 Medicare Part D cap is poised to make GLP-1s accessible to a population previously excluded by cost. State-level legislative actions continue to influence coverage for individual and group health plans, and Medicaid programs. This dynamic environment means that access and affordability are in constant flux.

Platforms like Push Health serve a critical role in this evolving landscape by democratizing access to prescribers. They offer a solution for patients